Breakthrough Psychedelic Drug Shows Promise in Treating Postpartum Depression
Reunion Neuroscience announced positive results from its RECONNECT Phase 2 clinical trial evaluating postpartum depression.
Read More
Reunion Neuroscience announced positive results from its RECONNECT Phase 2 clinical trial evaluating postpartum depression.
Read More
A single dose of psilocybin may provide relief from obsessive compulsive disorder symptoms for weeks or even months.
Read More
The Department of Justice failed to meet a January 16 deadline to publish new rules simplifying Schedule I research.
Read More
Integration therapy during the 24-72 hour neuroplastic window after ketamine determines whether results last. Learn what integration is, why it
Read More
The 8 best ketamine clinics in Richmond VA (2026), verified for in-network Spravato + TMS, neurodiagnostic-led psychiatry, KAP, and pricing
Read More
The 7 best ketamine clinics in Anchorage (2026), verified for $30-copay Spravato access, VA-approved IV ketamine, PMHNP-led KAP, and pricing
Read More
Brain scans are beginning to show a more detailed picture of how regular psychedelic users may process emotional threat. Single
Read More
A study reports symptom improvement among patients in Mindbloom’s at-home ketamine injections. However, this was not an independent test.
Read More
A JAMA Network Open study followed 346 people through Oregon's licensed psilocybin program. The adverse events showed up long after
Read More
A nootropic drug is one that may enhance brain performance. And a new study suggests LSD may be classified in
Read More